• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GNG7在结直肠癌中的预后价值及其与免疫浸润的关系

The Prognostic Value of GNG7 in Colorectal Cancer and Its Relationship With Immune Infiltration.

作者信息

Fang Can, Zhong Rulei, Qiu Chenyang, Zou Bing-Bing

机构信息

Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China.

出版信息

Front Genet. 2022 Feb 23;13:833013. doi: 10.3389/fgene.2022.833013. eCollection 2022.

DOI:10.3389/fgene.2022.833013
PMID:35281820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8906903/
Abstract

: G Protein Subunit Gamma 7 (GNG7) is an important gene that regulates cell proliferation and induces apoptosis. However, the correlation between GNG7 expression and immune infiltration as well as patient prognosis of colorectal cancer (CRC) remains unclear. : The GNG7 expression differences between tumor tissues and normal tissues were explored via the Oncomine database, Tumor Immune Estimation Resource (TIMER) site and UALCAN database. Then, the influence of GNG7 on clinical prognosis were evaluated, using the PrognoScan database. In addition, the relationship between GNG7 and tumor-related immune infiltration as well as gene marker sets of immune infiltration was investigated via TIMER, TISIDB and GEPIA. : We found that GNG7 expression was down-regulated in multiple malignant tumors including colorectal cancer (CRC) and the GNG7 expression was associated with tumor stage, histology subtype, lymph node metastasis and poor prognosis in colorectal cancer (CRC). In addition, the expression of GNG7 was significantly associated with infiltration level of multiple immune cells, immunomodulatory factors as well as part of the immune cell markers. : GNG7 displays validated prognostic value in CRC and was associated with its immune cell infiltration and immunoregulation. These results suggest that GNG7 is a potential prognostic marker and is associated with tumor immune infiltration, thus providing a new perspective for the immunotherapy of CRC.

摘要

G蛋白亚基γ7(GNG7)是一个调节细胞增殖并诱导细胞凋亡的重要基因。然而,GNG7表达与免疫浸润以及结直肠癌(CRC)患者预后之间的相关性仍不清楚。

通过Oncomine数据库、肿瘤免疫评估资源(TIMER)网站和UALCAN数据库探索肿瘤组织与正常组织之间的GNG7表达差异。然后,使用PrognoScan数据库评估GNG7对临床预后的影响。此外,通过TIMER、TISIDB和GEPIA研究GNG7与肿瘤相关免疫浸润以及免疫浸润基因标志物集之间的关系。

我们发现GNG7表达在包括结直肠癌(CRC)在内的多种恶性肿瘤中下调,并且GNG7表达与结直肠癌(CRC)的肿瘤分期、组织学亚型、淋巴结转移和不良预后相关。此外,GNG7的表达与多种免疫细胞、免疫调节因子以及部分免疫细胞标志物的浸润水平显著相关。

GNG7在CRC中显示出有效的预后价值,并且与其免疫细胞浸润和免疫调节相关。这些结果表明,GNG7是一种潜在的预后标志物,与肿瘤免疫浸润相关,从而为CRC的免疫治疗提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/b7f3720aa1db/fgene-13-833013-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/c98d073189c4/fgene-13-833013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/513f1958291c/fgene-13-833013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/913dedcd093e/fgene-13-833013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/46dc0a52c45b/fgene-13-833013-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/c13bbd20e5f4/fgene-13-833013-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/9e7713832c8f/fgene-13-833013-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/d1b1d1345507/fgene-13-833013-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/b7f3720aa1db/fgene-13-833013-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/c98d073189c4/fgene-13-833013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/513f1958291c/fgene-13-833013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/913dedcd093e/fgene-13-833013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/46dc0a52c45b/fgene-13-833013-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/c13bbd20e5f4/fgene-13-833013-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/9e7713832c8f/fgene-13-833013-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/d1b1d1345507/fgene-13-833013-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/8906903/b7f3720aa1db/fgene-13-833013-g008.jpg

相似文献

1
The Prognostic Value of GNG7 in Colorectal Cancer and Its Relationship With Immune Infiltration.GNG7在结直肠癌中的预后价值及其与免疫浸润的关系
Front Genet. 2022 Feb 23;13:833013. doi: 10.3389/fgene.2022.833013. eCollection 2022.
2
Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.综合分析确定GNG7作为肺腺癌中与免疫浸润相关的预后生物标志物。
Front Genet. 2022 Sep 9;13:984575. doi: 10.3389/fgene.2022.984575. eCollection 2022.
3
[Bioinformatic analysis of the relationship between protein phosphatase 2A catalytic subunit alpha (PPP2CA) expression and prognosis and immune infiltration in colorectal cancer patients].[蛋白质磷酸酶2A催化亚基α(PPP2CA)表达与结直肠癌患者预后及免疫浸润关系的生物信息学分析]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 Jul;40(7):591-604.
4
MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.MTUS1 是结直肠癌有前途的诊断和预后生物标志物。
World J Surg Oncol. 2022 Aug 13;20(1):257. doi: 10.1186/s12957-022-02702-2.
5
Prognostic and Immunological Role of THBS2 in Colorectal cancer.THBS2 在结直肠癌中的预后和免疫作用。
Biomed Res Int. 2021 Aug 21;2021:1124985. doi: 10.1155/2021/1124985. eCollection 2021.
6
SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.SEMA6B高表达预示结直肠癌预后不良并与肿瘤免疫抑制微环境相关。
Front Mol Biosci. 2021 Dec 6;8:687319. doi: 10.3389/fmolb.2021.687319. eCollection 2021.
7
USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance.USP20是结直肠癌预后不良的一个预测指标,且与淋巴结转移、免疫浸润及化疗耐药相关。
Front Oncol. 2023 Feb 16;13:1023292. doi: 10.3389/fonc.2023.1023292. eCollection 2023.
8
ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer.ETV1 与结直肠癌中的免疫浸润和不良临床预后呈正相关。
Front Immunol. 2022 Jul 4;13:939806. doi: 10.3389/fimmu.2022.939806. eCollection 2022.
9
Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.不同紧密连接蛋白基因表达的预后相关性评估突显紧密连接蛋白4在结直肠癌中被转化生长因子β1抑制剂所抑制。
Front Genet. 2022 Feb 24;13:783016. doi: 10.3389/fgene.2022.783016. eCollection 2022.
10
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.LAYN 是胃癌和结肠癌的预后生物标志物,并与免疫浸润相关。
Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.

引用本文的文献

1
Integrated genomic analysis of the stemness index signature of mRNA expression predicts lung adenocarcinoma prognosis and immune landscape.mRNA表达干性指数特征的综合基因组分析预测肺腺癌的预后和免疫格局。
PeerJ. 2025 Feb 13;13:e18945. doi: 10.7717/peerj.18945. eCollection 2025.
2
CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis.CD8 + T细胞相关基因:解读它们在胰腺腺癌肿瘤微环境中的作用及其对预后的影响
Dig Dis Sci. 2025 Jan;70(1):262-284. doi: 10.1007/s10620-024-08715-z. Epub 2024 Nov 27.
3
A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer.

本文引用的文献

1
Writing a strong scientific paper in medicine and the biomedical sciences: a checklist and recommendations for early career researchers.撰写医学和生物医学科学领域的高质量科研论文:给早期职业研究人员的清单及建议
Biol Futur. 2021 Dec;72(4):395-407. doi: 10.1007/s42977-021-00095-z. Epub 2021 Jul 28.
2
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.粪便样本中SDC2和TFPI2甲基化作为早期检测结直肠癌的综合生物标志物
Cancer Manag Res. 2021 Apr 30;13:3601-3617. doi: 10.2147/CMAR.S300861. eCollection 2021.
3
G protein gamma 7 suppresses progression of lung adenocarcinoma by inhibiting E2F transcription factor 1.
基于γ-氨基丁酸特征的新型风险评分模型可预测乳腺癌患者的生存预后。
Front Oncol. 2023 Mar 8;13:1108823. doi: 10.3389/fonc.2023.1108823. eCollection 2023.
4
Single-cell RNA sequencing analysis to explore immune cell heterogeneity and novel biomarkers for the prognosis of lung adenocarcinoma.单细胞RNA测序分析以探索肺腺癌预后的免疫细胞异质性和新型生物标志物。
Front Genet. 2022 Aug 15;13:975542. doi: 10.3389/fgene.2022.975542. eCollection 2022.
5
Transcriptomic Analysis of Circulating Leukocytes Obtained during the Recovery from Clinical Mastitis Caused by in Holstein Dairy Cows.荷斯坦奶牛临床型乳腺炎康复期循环白细胞的转录组分析。 (注:原文中“caused by ”这里有缺失信息)
Animals (Basel). 2022 Aug 21;12(16):2146. doi: 10.3390/ani12162146.
G 蛋白 γ 7 通过抑制 E2F 转录因子 1 抑制肺腺癌的进展。
Int J Biol Macromol. 2021 Jul 1;182:858-865. doi: 10.1016/j.ijbiomac.2021.04.082. Epub 2021 Apr 14.
4
Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics Approach.探索COL11A1基因在人类结直肠癌中的差异表达及预后意义:一种综合生物信息学方法
Front Genet. 2021 Feb 1;12:608313. doi: 10.3389/fgene.2021.608313. eCollection 2021.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Chemo-immunotherapy as first-line treatment for small-cell lung cancer.化疗免疫疗法作为小细胞肺癌的一线治疗方法。
Ther Adv Med Oncol. 2020 Dec 18;12:1758835920980365. doi: 10.1177/1758835920980365. eCollection 2020.
7
Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.结直肠癌免疫浸润:对患者预后和免疫治疗疗效的意义。
Front Immunol. 2020 May 28;11:1052. doi: 10.3389/fimmu.2020.01052. eCollection 2020.
8
Dendritic Cells and Their Role in Immunotherapy.树突状细胞及其在免疫疗法中的作用。
Front Immunol. 2020 May 21;11:924. doi: 10.3389/fimmu.2020.00924. eCollection 2020.
9
Immunotherapy, Inflammation and Colorectal Cancer.免疫疗法、炎症与结直肠癌
Cells. 2020 Mar 4;9(3):618. doi: 10.3390/cells9030618.
10
Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice.评估人癌组织中肿瘤相关巨噬细胞向M1和M2表型的极化:常规临床实践中的技术细节与挑战
Front Oncol. 2020 Jan 24;9:1512. doi: 10.3389/fonc.2019.01512. eCollection 2019.